Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
88,059,438
-
Number of holders
-
95
-
Total 13F shares, excl. options
-
35,430,856
-
Shares change
-
+466,205
-
Total reported value, excl. options
-
$488,943,386
-
Value change
-
+$8,388,194
-
Number of buys
-
37
-
Number of sells
-
-51
-
Price
-
$13.8
Significant Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q2 2022
112 filings reported holding IDYA - IDEAYA Biosciences, Inc. - Common Stock as of Q2 2022.
IDEAYA Biosciences, Inc. - Common Stock (IDYA) has 95 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35,430,856 shares
of 88,059,438 outstanding shares and own 40.24% of the company stock.
Largest 10 shareholders include Logos Global Management LP (3,750,000 shares), Avidity Partners Management LP (2,972,947 shares), BVF INC/IL (2,794,859 shares), Canaan Partners X LLC (2,660,713 shares), BlackRock Inc. (2,622,288 shares), BOXER CAPITAL, LLC (2,202,812 shares), FEDERATED HERMES, INC. (2,162,091 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,886,252 shares), VANGUARD GROUP INC (1,752,841 shares), and Point72 Asset Management, L.P. (1,509,000 shares).
This table shows the top 95 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.